The global hepatitis diagnostics test market is expected to reach USD 6.9 billion by 2025, according to a new report by Grand View Research, Inc. The rise in cases of hepatitis A, B & C is prominent as compared to D & E. World Health Organization (WHO), reports state 90% of children (before the age of 10 years), in developing countries are infected with hepatitis A virus. The reports by the WHO also states that 257 million people were suffering from hepatitis B virus infection, and 71 million people were affected by the hepatitis C in 2016.
The government, NGOs and non-profitable organizations play an important role in creating awareness of diseases by providing correct information about the condition, symptoms and detection techniques. Rise in awareness regarding the disease is positively impacting the market growth with increase in demand for diagnostic tests. Also, the technological developments such as molecular diagnostics involving DNA and RNA testing is contributing in the market growth.
Hence, factors such as rising awareness regarding availability of screening and monitoring procedures, growing prevalence of hepatitis and increasing demand for rapid diagnostic techniques are expected to propel the global market over the forecast period.
Access Full research report on Hepatitis Diagnostics Test Market Analysis:
https://www.grandviewresearch.com/industry-analysis/hepatitis-therapeutics-market
Further key findings from the study suggest:
-
The growing prevalence rate of hepatitis (A, B, C, D & E) is primarily driving the market growth
-
The blood tests segment is further segmented in to liver function tests, immunoassays & nucleic acid assays
-
The blood tests dominate the market and are expected to exhibit fastest growth rate over the forecast period, owing to their affordability and higher adoption volume as compared to other tests
-
The liver function tests hold a significant share of the market since these tests are the first line diagnostics and are prerequisite for further analytical examinations required to be performed for confirmation of virus causing the disease
-
North America dominated in 2016, owing to rising prevalence, various government initiatives creating awareness regarding rising incidences, treatment & availability of diagnostic test options, and highly developed healthcare infrastructure
-
Constant rise in the new cases of hepatitis is observed in Asia Pacific. Thus, this region is expected to witness a rapid growth during the forecast period.
-
Some of the major players competing include, but are not limited to Abbott Laboratories; Danaher Corporation; F. Hoffmann Roche; DiaSorin S.p.A; MedMira, Inc.; Siemens Ag, bioMeriuex SA; Hologic, Inc.; and Bio Rad Laboratories.
-
These players dominate the market with their strong brand identity and extensive geographic reach by their strategic initiatives such as mergers & acquisition and partnership with other players.
View more reports of this category by Grand View Research at:
https://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the hepatitis diagnostics test market report on the basis of diagnostic tests and region:
Diagnostic Tests Outlook (Revenue, USD Million; 2014 – 2025)
-
Blood tests
-
Liver function tests
-
Immunoassays
-
Nucleic Acid Tests
-
-
Imaging Tests
-
Liver Biopsy
Regional Outlook (Revenue, USD Million; 2014 – 2025)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
Germany
-
UK
-
-
Asia Pacific
-
China
-
Japan
-
-
Latin America
-
Mexico
-
Brazil
-
-
MEA
-
South Africa
Access Full Press Of This Report By Grand View Research: https://www.grandviewresearch.com/press-release/global-hepatitis-therapeutics-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: sales@grandviewresearch.com
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/hepatitis-therapeutics-market